BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20727040)

  • 1. Molecular underpinning of B-cell anergy.
    Yarkoni Y; Getahun A; Cambier JC
    Immunol Rev; 2010 Sep; 237(1):249-63. PubMed ID: 20727040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of anergic B cells within a wild-type repertoire.
    Merrell KT; Benschop RJ; Gauld SB; Aviszus K; Decote-Ricardo D; Wysocki LJ; Cambier JC
    Immunity; 2006 Dec; 25(6):953-62. PubMed ID: 17174121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of autoreactive B cells by anergy: a fresh perspective.
    Gauld SB; Merrell KT; Cambier JC
    Curr Opin Immunol; 2006 Jun; 18(3):292-7. PubMed ID: 16616480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell activation versus anergy; the antigen receptor as a molecular switch.
    Cambier JC; Getahun A
    Immunol Lett; 2010 Jan; 128(1):6-7. PubMed ID: 19808046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell anergy: from transgenic models to naturally occurring anergic B cells?
    Cambier JC; Gauld SB; Merrell KT; Vilen BJ
    Nat Rev Immunol; 2007 Aug; 7(8):633-43. PubMed ID: 17641666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
    Vilen BJ; Burke KM; Sleater M; Cambier JC
    J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.
    Gauld SB; Benschop RJ; Merrell KT; Cambier JC
    Nat Immunol; 2005 Nov; 6(11):1160-7. PubMed ID: 16200069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
    Kat I; Makdasi E; Fischel R; Eilat D
    Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.
    Szodoray P; Stanford SM; Molberg Ø; Munthe LA; Bottini N; Nakken B
    J Allergy Clin Immunol; 2016 Sep; 138(3):839-851.e8. PubMed ID: 27056269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of anergy in CD8 T cells by B cell presentation of antigen.
    Höllsberg P; Batra V; Dressel A; Hafler DA
    J Immunol; 1996 Dec; 157(12):5269-76. PubMed ID: 8955172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors.
    Duty JA; Szodoray P; Zheng NY; Koelsch KA; Zhang Q; Swiatkowski M; Mathias M; Garman L; Helms C; Nakken B; Smith K; Farris AD; Wilson PC
    J Exp Med; 2009 Jan; 206(1):139-51. PubMed ID: 19103878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
    Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
    J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate.
    Cyster JG; Goodnow CC
    Immunity; 1995 Dec; 3(6):691-701. PubMed ID: 8777715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity.
    Burnett DL; Reed JH; Christ D; Goodnow CC
    Immunol Rev; 2019 Nov; 292(1):61-75. PubMed ID: 31556969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the proapoptotic protein, Bim, breaks B cell anergy.
    Oliver PM; Vass T; Kappler J; Marrack P
    J Exp Med; 2006 Mar; 203(3):731-41. PubMed ID: 16520387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgD attenuates the IgM-induced anergy response in transitional and mature B cells.
    Sabouri Z; Perotti S; Spierings E; Humburg P; Yabas M; Bergmann H; Horikawa K; Roots C; Lambe S; Young C; Andrews TD; Field M; Enders A; Reed JH; Goodnow CC
    Nat Commun; 2016 Nov; 7():13381. PubMed ID: 27830696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
    Dörner T; Szelinski F; Lino AC; Lipsky PE
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32675278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.